Pinnacle Financial Group’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$377K Buy
1,732
+202
+13% +$44.8K 0.1% 81
2025
Q4
$350K Buy
1,530
+67
+5% +$15.3K 0.1% 82
2025
Q3
$339K Buy
1,463
+37
+3% +$7.54K 0.1% 81
2025
Q2
$265K Buy
1,426
+47
+3% +$8.73K 0.09% 81
2025
Q1
$289K Buy
1,379
+8
+0.6% +$1.55K 0.11% 75
2024
Q4
$244K Buy
1,371
+14
+1% +$2.57K 0.1% 76
2024
Q3
$268K Buy
1,357
+13
+1% +$2.43K 0.11% 71
2024
Q2
$231K Sell
1,344
-12
-0.9% -$1.99K 0.1% 66
2024
Q1
$247K Hold
1,356
0.11% 62
2023
Q4
$210K Sell
1,356
-842
-38% -$123K 0.11% 62
2023
Q3
$328K Sell
2,198
-80
-4% -$11.7K 0.2% 51
2023
Q2
$307K Hold
2,278
0.17% 52
2023
Q1
$363K Buy
2,278
+55
+2% +$8.41K 0.22% 50
2022
Q4
$359K Buy
2,223
+10
+0.5% +$1.53K 0.25% 47
2022
Q3
$297K Hold
2,213
0.26% 46
2022
Q2
$339K Hold
2,213
0.29% 39
2022
Q1
$359K Sell
2,213
-202
-8% -$29.3K 0.29% 42
2021
Q4
$327K Buy
+2,415
New +$285K 0.25% 47

Other funds holding ABBV

Pinnacle Financial Group's ABBV Position: Q1 2026 in Review

Pinnacle Financial Group increased its AbbVie (ABBV) stake by 13% in Q1 2026, buying an estimated $44.8K and bringing the position to 1,732 shares worth $377K. The position accounts for 0.1% of the portfolio, ranked #81.

Pinnacle Financial Group first reported a position in ABBV in Q4 2021 and has held it in 18 quarters since. 4,076 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Pinnacle Financial Group held 1,732 shares of AbbVie worth $377K as of Q1 2026.
  • Pinnacle Financial Group bought 202 AbbVie shares in Q1 2026, an estimated $44.8K.
  • AbbVie made up 0.1% of Pinnacle Financial Group's portfolio in Q1 2026, its #81 holding.
  • Pinnacle Financial Group first reported a position in AbbVie in Q4 2021 and has held it in 18 quarters since.
  • 4,076 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Pinnacle Financial Group's 13F filing for Q1 2026, filed 13 May 2026.